Editorial introductions
Advanced renal cell carcinoma: what to do after first line antiangiogenic therapy?
Cytoreductive nephrectomy in metastatic renal cell carcinoma: the evolving role of surgery in the era of molecular targeted therapy
Predicting life expectancy in prostate cancer patients
Management of sorafenib, sunitinib, and temsirolimus toxicity in metastatic renal cell carcinoma
The current management of small renal masses
Management of depression in the last month of life
Health services research on end-of-life care
Nutrition in the last days of life
Determining prognosis and predicting survival in end-of-life care
Advances in the treatment of neutropenia
New results from the use of bisphosphonates in cancer patients
Vertebral augmentation in osteoporotic and osteolytic fractures
Current World Literature